Navigation Links
Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications

The Institute of Bioengineering and Nanotechnology (IBN) has developed a novel method to simultaneously control the size and morphology of nanoparticles, which can be used in pharmaceutical synthesis and novel biomedical applications.

This groundbreaking research was recently featured in the leading Chemistry journal, Angewandte Chemie, and a United States patent has been filed on the invention.

Research Scientist Dr. Yu Han and IBN Executive Director Prof. Jackie Y. Ying have developed a fluorocarbon-mediated-synthesis technique that produces nanometer-sized particles of between 50 and 300 nm with tunable pore sizes in the range of 5-30 nm (The width of a human hair is approximately 80,000 nm).

“The nanoporous nanoparticles are named after our Institute, termed ‘IBN-1?to ‘IBN-5? They represent a new class of materials that are tailored simultaneously with nanometer-scale particle size and nanometer-sized pores. This is a beautiful example of ‘bottom-up?nanotechnology made possible by supramolecular chemistry,?said Prof. Ying.

Previous attempts at synthesizing such nanoparticles created particles that were limited in the type of structure, degree of structural ordering and range of pore sizes. Most current technologies can only produce 2-dimensional hexagonal structure with small pore diameter (< 5 nm). In many cases, special vapor-phase synthesis equipment is required.

IBN’s simple wet-chemical technique uses two different types of surfactant (a soluble chemical compound that reduces the surface tension between liquids). One surfactant acts as the template for mesoporous structure, while the other is used to limit the growth of the particles to nanometer dimensions.

This method can be used to create a variety of nanoparticles with enormous surface areas, and very well-defined pore size and structure.

One important application of these nanoporous nanoparticles lies in the production of pure chiral drugs, which m
'"/>

Source:www.ibn.a-star.edu.sg


Page: 1 2

Related biology news :

1. Breakthrough Microarray-based Technology for the Study of Cancer
2. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
3. Breakthrough isolating embryo-quality stem cells from blood
4. Breakthrough System for Understanding Ocean Plant Life Announced
5. Breakthrough: Scientists create worlds tiniest organic particles
6. Breakthrough in micro-device fabrication combines biology and synthetic chemistry
7. Sciences Breakthrough of the Year: Watching evolution in action
8. Breakthrough for stem cell research
9. Breakthrough in understanding type-2 diabetes as key genes identified
10. Breakthrough vaccine to treat chemo-resistant ovarian cancer
11. Color-blind method opens new doors in DNA sequencing

Post Your Comments:
(Date:11/19/2009)...tries of the world. It is widely used for human co...It also is considered an exemplar plant species fo... genome architecture. The authors of the research ...t description of the B73 maize genome to probe som... plant biology. The ten papers consider maize cent...
(Date:11/19/2009)... multi-institutional effort co-led by three Cold S...ed today in publication of a landmark series of pa...dented detail the DNA sequence of maize ( Zea mays...rth American consumers, is one of the world,s most...al crop grown in the United States, representing $...
(Date:11/19/2009)...swire-FirstCall/ -- BIO-key International, Inc. (O...lic safety and finger-based biometric identificati...er Meeting held today was adjourned without any ac... ,, (Logo: http://www.newscom.com/cgi-bin/prnh....3% of the 35 million votes cast voted in favor of...
Breaking Biology News(10 mins):PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Finally The Round Diet 21 A Diet Simple Enough that Even a Kindergartener Can Follow It 50523 1Finally The Round Diet 21 A Diet Simple Enough that Even a Kindergartener Can Follow It 50523 2WellPoint Recovers and Saves 2475 Million Through Anti Fraud Programs and Investigations in 2008 50521 1WellPoint Recovers and Saves 2475 Million Through Anti Fraud Programs and Investigations in 2008 50521 2WellPoint Recovers and Saves 2475 Million Through Anti Fraud Programs and Investigations in 2008 50521 3Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 1Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 2Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 3Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 4Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 5
...t suffering from depression. Children take on an e...t and for other family members. It is therefore im...s and have support functions in place for the whol...This is the conclusion of a thesis from the Sahlgr... Registered Nurse Britt Hedman Ahlstrm has examin...
...daq: AWRE ), a leading supplier of broadband tec...hat its Board of Directors has approved a modified...00 shares, or approximately 15%, of its outstandin... share purchase rights), at a price in the range o...e purchase price of approximately $9.1 million. T...
...man, co-author of the study titled "Drought Sensit... of the TEAM Network at Conservation International...ing on energy security and food security, this stu...tem security in short, how nature keeps us health... problem; drying climate is just as bad or worse f...
Other Biology News:Children seriously affected when a parent suffers from depression 2Aware, Inc. Commences Dutch Auction Tender Offer 2Aware, Inc. Commences Dutch Auction Tender Offer 3Aware, Inc. Commences Dutch Auction Tender Offer 4
(Date:11/19/2009)... InSound is honored by latest award fo... Newark, CA (PRWEB) November 16, 2009 -- Popu...visible” hearing aid from InSound Medical a ...rd in the Health category.    ...ed to reside deep in the hearing canal for up to f...
(Date:11/18/2009)...y personnel need to be able to find explosive mate...em. To aid such searches, the National Institute o...om the Department of Homeland Security, has develo...eference Material (SRM) 2905, Trace Particulate Ex...ay methods, the SRM will be helpful in calibrating...
(Date:11/18/2009)... Vernier,s experience in data analysis combined wi...am kits and curricula provide state-of-the...BEAVERTON, Ore., Nov. 18 Vernier S...l science interfaces, sensors, and software and Bi...urer and distributor of life science research and ...
(Date:11/18/2009)...SISSAUGA, ON, Nov. 18 /PRNewswire-FirstCall/ - YM ...fe sciences product development company that ident...g cancer-related products at various stages of dev...uating nimotuzumab were presented today in a poste... Cancer Therapeutics conference in Boston, Massach...
Breaking Biology Technology:Popular Science Awards Lyric &#8220;Invisible&#8221; Hearing Aid 2009 &#8220;Best of What's New&#8221; Award 2Popular Science Awards Lyric &#8220;Invisible&#8221; Hearing Aid 2009 &#8220;Best of What's New&#8221; Award 3New NIST trace explosives standard slated for homeland security duty 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3
...enosumab is a new drug being,studied to prevent fr...al,therapy. Results of a phase 3 clinical trial us... San Antonio Breast Cancer Symposium by Georgiana,... Denosumab is a highly specific antibody that int...zed cells that break down bone. Because it is,high...
...ontinuing Interest in Peregrine,s Anti-PS Technolo... -, TUSTIN, Calif., Dec. 14 Peregrine,Pharmaceut...pharmaceutical,company developing monoclonal antib...virus (HCV) infection, today announced the sudden ...ract award with the Defense Threat,Reduction Agenc...
...l Potential Uses, Excluding U.S. and Japan, No Ot...ase BASINGSTOKE, England and PHILADELPHIA, Decemb...Q),the global specialty biopharmaceutical company,...e rights, excluding the U.S. and Japan, to AT-1001...1 is Alba,s lead inhibitor,of barrier dysfunction ...
Other Biology Technology:New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment 2Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program 2Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program 3Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program 4Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation 2Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation 3
mirVana™ qRT-PCR Primer Set for Normalization (5S) from Ambion
Rabbit Anti-Human JUB Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Caspase-8 Inhibitor Z-IETD-FMK from BioVision
GIBCO MEM Non-Essential Amino Acids Solution 10 mM (100X), liquid from Invitrogen
Biology Products: